High Quality
Open the downloaded document, and select print from the file menu (PDF reader required).
National Consultation onHIV and HCV Treatment Access Issues
NEW DELHI, INDIA
ORGANIZED BY:
INTERNATIONAL TREATMENT PREPAREDNESS COALITION
–
INDIA
(
ITPC
–
India
)
2 |
National Consultation on HIV and HCV TreatmentAccess Issues, New Delhi, India |
19-20 October 2011
INTERNATIONAL TREATMENT PREPAREDNESS COALITION - SOUTH ASIA
(ITPC
–
SOUTH ASIA)
The International TreatmentPreparedness Coalition (ITPC) whichstarted focussing on
South Asia
in 2004has supported over 95 community-basedorganizations in India, Pakistan, Nepal,Bangladesh and Sri Lanka in this region
through its HIV Collaborative Fund. The ITPC‟s global Secretariat is based in
Bangkok at the offices of the Asian Pacific Network of People Living with HIV(APN+). South Asia regional coordination of ITPC activities is managed byLoon Gangte, who is a noted treatment activist in India since 1997 and alsoa founder of the Delhi Network of People Living with HIV (DNP+).
INTERNATIONAL TREATMENT PREPAREDNESS COALITION
–
INDIA
(ITPC
–
INDIA)
To strengthen country-level treatment preparedness advocacy in India,ITPC-India was formed in September 2008. ITPC-India is a national coalitionof people living with HIV, treatment activists, doctors, lawyers, academia,among others; all of whom have strong expertise in HIV, tuberculosis (TB)and hepatitis C (Hep-C) treatment and other related interventions.The goal of ITPC-India is to
“Accelerate treatment access in India throughadvocacy and treatment literacy”.
ITPC-India plans to advocate andcontribute to the national HIV programme by involving and providingscientific information and strategic direction.
PHOTO CREDIT AND DOCUMENT PRODUCTION
Bobby Ramakant,
CNS
: www.
citizen-news.org
Layout, design, and support: Shobha Shukla, Jittima Jantanamalaka
October 2011
3 |
National Consultation on HIV and HCV TreatmentAccess Issues, New Delhi, India |
19-20 October 2011
TABLE OF CONTENTS
About the consultation
………………………………………………………
.
.
5
Session I:
Hepatitis C: a global health problem………………….. 7
Session II:
Safeguards in NDPS Act for
PUD…………………………. 14
Session III:
Treating
HCV……………………………………………………… 18
Session IV:
Barriers to access to HCV treatment………………… 20
Session V:
Personal testimonies of people with HCV…………. 24
Session VI:
Interaction with 30 judges/ police officers……… 29
Session VII:
Access to medicines and treatment is
critical to Right to Health framework……………........
34
Session VIII:
Patent barriers to access to HCV medicines…….
37
Session IX:
Seeking
p
hase
out Stavudine (d4T)………………
..
…. 40
Session X:
Brainstorming on issues for UN agencies, NACO,
Planning Commission and other stakeholders……………………
.
… 5
1
Annexure I:
List of participants
………………………
.
………………… 53
Annexure II:
Press release on Hep C
…………………
.
………………. 5
4
Annexure III
: Brief report of the meeting ofITPC-India with Planning
Commission…………………………………… 58
Annexure IV
: Notes from meeting of ITPC-Indiawith UN agenc
ies…………………………………………………………………… 59
Annexure V
: Major r
ecommendations………………………………... 6
3
Add a Comment